30-Oct-2024 5:20 AM CST - Business Wire GE HealthCare reports third quarter 2024 financial results GE HealthCare (Nasdaq: GEHC) today reported financial results for the third quarter ended September 30, 2024. GE HealthCare President and CEO Peter Arduini said, In the third quarter, we reported sales and orders growth of 1% globally. Both sales and orders grew in the mid-single digits excluding China, with particular strength in the U.S. across all segments. Pharmaceutical Diagnostics also delivered solid performance, driven by healthy procedure volumes. Ongoing lea
8-Oct-2024 7:00 AM CST - Business Wire GE HealthCare to announce third quarter 2024 results on October 30, 2024 GE HealthCare (Nasdaq: GEHC) will announce its third quarter 2024 financial results before the market opens on Wednesday, October 30, 2024. The GE HealthCare management team will also host a conference call and webcast at 8:30 a.m. Eastern Time / 7:30 a.m. Central Time on that same day, which will be a live webcast and accessible at https://investor.gehealthcare.com/news-events/events. The earnings release, accompanying financial information, and webcast replay also wi
7-Oct-2024 9:12 AM CST - Business Insider GE HealthCare Joins Thera4Care GE HealthCare announced the commencement of Thera4Care, an initiative aimed at revolutionizing the use of theranostics to broaden
30-Sep-2024 12:13 PM CST - Yahoo Finance GE HealthCare Stock Likely to Rise After FDA Approval of Flyrcado GEHC's Flyrcado, a first-of-its-kind PET tracer for coronary artery disease, receives FDA approval, expanding diagnostic access and improving patient outcomes.
27-Sep-2024 5:15 PM CST - Investing US FDA approves GE HealthCare's diagnostic drug for heart disease The U.S. Food and Drug Administration approved GE HealthCare (NASDAQ: GEHC)'s diagnostic drug for use in detection of coronary artery disease, the company said on Frid
23-Sep-2024 12:17 PM CST - Investing GE HealthCare Technologies Inc (GEHC) GE HealthCare (Nasdaq: NASDAQ:GEHC) announces the latest innovation in electrophysiology (EP), the Prucka 3 with CardioLab EP Recording system, to help clinicians in the diagnosis... CHICAGO - GE HealthCare (NASDAQ:GEHC) announced today its agreement to ...
20-Sep-2024 9:58 AM CST - Zacks GE HealthCare Shares Rise After AI-Powered Venue Sprint's Launch GEHC introduces Venue Sprint, a portable AI-enabled ultrasound device offering wireless probes, real-time insights and advanced clinical tools for improved care.
30-Oct-2024 5:20 AM CST - Business Wire GE HealthCare reports third quarter 2024 financial results GE HealthCare (Nasdaq: GEHC) today reported financial results for the third quarter ended September 30, 2024. GE HealthCare President and CEO Peter Arduini said, In the third quarter, we reported sales and orders growth of 1% globally. Both sales and orders grew in the mid-single digits excluding China, with particular strength in the U.S. across all segments. Pharmaceutical Diagnostics also delivered solid performance, driven by healthy procedure volumes. Ongoing lea
8-Oct-2024 7:00 AM CST - Business Wire GE HealthCare to announce third quarter 2024 results on October 30, 2024 GE HealthCare (Nasdaq: GEHC) will announce its third quarter 2024 financial results before the market opens on Wednesday, October 30, 2024. The GE HealthCare management team will also host a conference call and webcast at 8:30 a.m. Eastern Time / 7:30 a.m. Central Time on that same day, which will be a live webcast and accessible at https://investor.gehealthcare.com/news-events/events. The earnings release, accompanying financial information, and webcast replay also wi
7-Oct-2024 9:12 AM CST - Business Insider GE HealthCare Joins Thera4Care GE HealthCare announced the commencement of Thera4Care, an initiative aimed at revolutionizing the use of theranostics to broaden
30-Sep-2024 12:13 PM CST - Yahoo Finance GE HealthCare Stock Likely to Rise After FDA Approval of Flyrcado GEHC's Flyrcado, a first-of-its-kind PET tracer for coronary artery disease, receives FDA approval, expanding diagnostic access and improving patient outcomes.
27-Sep-2024 5:15 PM CST - Investing US FDA approves GE HealthCare's diagnostic drug for heart disease The U.S. Food and Drug Administration approved GE HealthCare (NASDAQ: GEHC)'s diagnostic drug for use in detection of coronary artery disease, the company said on Frid
23-Sep-2024 12:17 PM CST - Investing GE HealthCare Technologies Inc (GEHC) GE HealthCare (Nasdaq: NASDAQ:GEHC) announces the latest innovation in electrophysiology (EP), the Prucka 3 with CardioLab EP Recording system, to help clinicians in the diagnosis... CHICAGO - GE HealthCare (NASDAQ:GEHC) announced today its agreement to ...
20-Sep-2024 9:58 AM CST - Zacks GE HealthCare Shares Rise After AI-Powered Venue Sprint's Launch GEHC introduces Venue Sprint, a portable AI-enabled ultrasound device offering wireless probes, real-time insights and advanced clinical tools for improved care.